Unione Europea - italiano - EMA (European Medicines Agency)

serb sas - glucarpidase - metabolic side effects of drugs and substances - tutti gli altri prodotti terapeutici - voraxaze is indicated to reduce toxic plasma methotrexate concentration in adults and children (aged 28 days and older) with delayed methotrexate elimination or at risk of methotrexate toxicity.